PB2366: TRIAL IN PROGRESS: PHASE 1 TRIAL EVALUATING THE SAFETY AND TOLERABILITY OF ODRONEXTAMAB IN COMBINATION WITH CEMIPLIMAB IN RELAPSED/REFRACTORY AGGRESSIVE B-CELL NON-HODGKIN... by Cecilia Carmen Carpio Segura, Manjusha Namuduri, Dishan Liu, Nickolas A. Sophos, Min Zhu, Ayesha Sabir, Jurriaan Brouwer-Visser, Aafia Chaudhry, Hesham Mohamed, Alejandro Martin Garcia-Sancho

Get full text

P1115: ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: RESULTS FROM A PRESPECIFIED ANALYSIS OF THE PIVOTAL PHASE 2 STUDY ELM-2 by Jan Walewski, Tae Min Kim, Seok-Goo Cho, Isidro Jarque, Elżbieta Iskierka-Jażdżewska, Michelle Poon, H. Miles Prince, Sung Yong Oh, Francesca Lim, Cecilia Carmen Carpio Segura, Tran-Der Tan, Sabarish Ayyappan, Antonio Gutiérrez, Jingjin LI, Melanie Ufkin, Min Zhu, Aafia Chaudhry, Hesham Mohamed, Srikanth Ambati, Won-Seog Kim

Get full text

P1151: BENDAMUSTINE-CONTAINING REGIMENS CAN BE SAFELY USED AS BRIDGING IN LARGE B-CELL LYMPHOMA PATIENTS RECEIVING CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY by Gloria Ines Iacoboni Garcia-Calvo, Victor Navarro, Ana Africa Martin Lopez, Mariana Bastos Oreiro, Kai Rejeski, Katarzyna Aleksandra Jalowiec, Paula Amat, Juan Luis Reguera Ortega, Viktoria Blumenberg, Laura Gallur, María Herrero-García, Claire Roddie, Rebeca Bailen, Ana Benzaquen, Cecilia Carmen Carpio Segura, Lucía López Corral, Rafael Hernani, MI Kwon, Lourdes Martín-Martín, Marion Subklewe, Maeve O’reilly6, Pere Barba Suñol

Get full text